Clinical Study
Evaluation of Hemodynamic Parameters as Predictors of Glaucoma Progression
Table 2
Color Doppler imaging parameters during 18 months of followup.
| Characteristics | DTFC | LTFC | value (t-test) |
| OA_PSV (cm/s) | Baseline | 23.79 (8.837) | 30.86 (9.30) | .042 | 1 month | 37.10 (12.33) | 36.04 (7.83) | .781 | 6 months | 38.15 (16.24) | 33.87 (8.27) | .371 | 12 months | 40.66 (15.51) | 42.50 (14.01) | .736 | 18 months | 33.70 (10.05) | 28.71 (6.93) | .125 |
| OA_EDV (cm/s) | Baseline | 4.82 (2.47) | 7.03 (3.60) | .06 | 1 month | 8.22 (4.22) | 8.78 (3.94) | .710 | 6 months | 8.87 (6.03) | 7.66 (2.52) | .479 | 12 months | 10.59 (4.79) | 9.63 (5.11) | .599 | 18 months | 9.47 (6.19) | 7.23 (4.54) | .268 |
| OA_RI | Baseline | 0.79 (0.11) | 0.76 (0.11) | .437 | 1 month | 0.79 (0.07) | 0.75 (0.11) | .158 | 6 months | 0.76 (0.11 ) | 0.76 (0.09) | .986 | 12 months | 0.72 (0.12) | 0.82 (0.17) | .046* | 18 months | 0.76 (0.10) | 0.87 (0.28) | .189 |
| CRA_PSV (cm/s) | Baseline | 15.09 (3.78) | 17.91 (7.80) | .218 | 1 month | 17.78 (4.43) | 18.59 (7.34) | .716 | 6 months | 19.08 (7.59) | 17.67 (5.95) | .575 | 12 months | 28.88 (13.40) | 22.71 (12.82) | .208 | 18 months | 18.69 (8.79) | 17.46 (5.24) | .645 |
| CRA_EDV (cm/s) | Baseline | 4.56 (1.81) | 6.33 (2.48) | .034* | 1 month | 6.49 (2.22) | 5.41 (3.19) | .291 | 6 months | 6.0 (2.49) | 6.16 (2.64) | .868 | 12 months | 7.56 (3.67) | 10.31 (7.34) | .204 | 18 months | 5.66 (2.80) | 6.85 (3.24) | .289 |
| CRA_RI | Baseline | 0.80 (0.26) | 0.81 (0.25) | .915 | 1 months | 0.68 (0.08)* | 0.80 (0.16)* | .011* | 6 months | 0.65 (0.082) | 0.72 (0.19) | .192 | 12 months | 0.74 (0.19) | 0.85 (0.19) | .000* | 18 months | 0.67 (0.09) | 0.93 (0.23) | .000* |
| SPCA_PSV (cm/s) | Baseline | 15.55 (4.70) | 14.50 (6.59) | .606 | 1 month | 15.95 (5.91) | 13.38 (3.10) | .147 | 6 months | 20.03 (6.42) | 17.92 (3.68) | .280 | 12 months | 21.01 (10.40) | 19.81 (7.04) | .715 | 18 months | 13.69 (5.45) | 11.03 (2.83) | .104 |
| SPCA_EDV (cm/s) | Baseline | 4.42 (2.29) | 14.50 (6.59) | .973 | 1 month | 4.69 (2.28) | 3.31 (2.11) | .095 | 6 months | 6.10 (2.16) | 5.47 (2.22) | .442 | 12 months | 6.04 (2.67)* | 3.43 (2.26)* | .007* | 18 months | 4.39 (1.85) | 3.87 (1.17) | .366 |
| SPCA_RI | Baseline | 0.71 (0.06) | 0.79 (0.28) | .232 | 1 month | 0.75 (0.08) | 0.79 (0.10) | .229 | 6 months | 0.69 (0.06) | 0.69 (0.11) | .969 | 12 months | 0.70 (0.07)* | 0.90 (0.27)* | .011* | 18 months | 0.69 (0.11)* | 0.85 (0.30)* | .015* |
|
|
*
statistically significant. DTFC: dorzolamide/timolol fixed combination; LTFC: latanoprost/timolol fixed combination; OA: ophthalmic artery; CRA: central retinal artery; SPCA: short posterior ciliary artery, PSV: peak systolic velocity; EDV: end diastolic velocity; RI: resistive index.
|